Intracameral Drug Delivery: A Review of Agents, Indications, and Outcomes
Journal of Ocular Pharmacology and Therapeutics · 2023
DOI: 10.1089/jop.2022.0144 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Ocular Pharmacology and Therapeutics, 2023. Verfasst von Megha Gautam und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, All India Institute of Medical Sciences, Bhopal, India. Hauptthemen laut MEDLINE: Cataract Extraction, Eye Infections, Bacterial, Endophthalmitis. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 158 Literaturangaben.
Abstract (Originalsprache)
An intracameral (IC) injection directly delivers the drug into the anterior chamber of the eye. This targeted drug delivery technique overcomes the ocular barriers and offers a high therapeutic concentration of medication at the desired site and consequently better clinical outcomes. IC drug delivery is a safe and effective modality with many advantages over topical delivery. These include excellent bioavailability, reduced systemic risk, and minimal ocular toxicity. Agents delivered via IC injection have shown promising results against infection, inflammation, ocular hypertension, and neovascularization. Current literature shows that IC antibiotics, including cefuroxime, vancomycin, and moxifloxacin, are routinely used for prophylaxis of endophthalmitis. Other drugs available for IC use are steroids, anesthetics, mydriatics, miotics, antivascular endothelial growth factor, antiglaucoma, and alkylating agents. Introduction of sustained-release devices containing dexamethasone or Bimatoprost in anterior chamber via IC route has the potential in treating ocular inflammation and raised intraocular pressure. The complications such as hemorrhagic occlusive retinal vasculitis and toxic anterior segment syndrome have been documented with IC prophylaxis but are rare. In this review, we provide an overview of available IC drugs, their pharmacokinetics, the spectrum of activity, dosage and preparation, prophylactic and therapeutic usage, clinical efficacy, and safety profiles.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, All India Institute of Medical Sciences, Bhopal, India.
- Department of Ophthalmology and Molecular Medicine, University of Missouri, Columbia, Missouri, USA.
ORCID-Profile: Rajiv R Mohan
Zitieren
APA
Gautam, M., Gupta, R., Singh, P., Verma, V., Verma, S., Mittal, P., Karkhur, S., Sampath, A., Mohan, R. R., & Sharma, B. (2023). Intracameral Drug Delivery: A Review of Agents, Indications, and Outcomes. Journal of Ocular Pharmacology and Therapeutics. https://doi.org/10.1089/jop.2022.0144
Vancouver
Gautam M, Gupta R, Singh P, Verma V, Verma S, Mittal P, et al. Intracameral Drug Delivery: A Review of Agents, Indications, and Outcomes. Journal of Ocular Pharmacology and Therapeutics. 2023. doi:10.1089/jop.2022.0144
BibTeX
@article{Gautam2023,
author = {Gautam, Megha and Gupta, Rituka and Singh, Priti and Verma, Vidhya and Verma, Sunil and Mittal, Parul and Karkhur, Samendra and Sampath, Ananyan and Mohan, Rajiv R and Sharma, Bhavana},
title = {Intracameral Drug Delivery: A Review of Agents, Indications, and Outcomes},
journal = {Journal of Ocular Pharmacology and Therapeutics},
year = {2023},
doi = {10.1089/jop.2022.0144}
}
EUVIMED